January 31st, 2019 – Xstrahl Medical, global leader in superficial radiotherapy devices and advanced radiation research systems, has been named the best specialty radiotherapy systems manufacturer in the 2018 Global Health & Pharma Awards. Xstrahl manufactures advanced radiotherapy systems for both clinical and pre-clinical applications at production facilities in the U.K. and U.S.
According to the award adjudicators, Xstrahl is ‘a growing company committed to providing effective clinical solutions to advance radiotherapy for treating cancer and dermatological conditions and pre-clinical research applications.’
“This award recognizes Xstrahl for our ongoing efforts to spread advanced cancer care globally and we are delighted to receive it,” said Adrian Treverton, Xstrahl’s chief executive officer. “There are a number of excellent radiotherapy system manufacturers, so for Xstrahl to be honoured in this way says a great deal about our ongoing commitment to fight cancer.”
For more than 15 years, Xstrahl’s medical systems have supported the X-ray therapy requirements of healthcare professionals and their patients in over 600 clinics around the world. In collaboration with internationally renowned researchers, Xstrahl has also applied its extensive medical X-ray knowledge to develop powerful and customizable radiation biology research systems for pre-clinical applications.
Global Health & Pharma is a global information sharing platform and its annual technology awards were established to recognize the important contributions made by companies and individuals who are dedicated to enhancing the quality of healthcare globally and create innovative healthcare solutions for individuals across the world.